Alveolar bone resorption results from the inflammatory response to periodontal pathogens. Systemic diseases that affect the host response, such as type 1 diabetes mellitus (DM1), can potentiate the severity of periodontal disease (PD) and accelerate bone resorption. However, the biological mechanisms by which DM1 modulates PD are not fully understood. The aim of this study was to determine the influence of DM1 on alveolar bone resorption and to evaluate the role of receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) in osteoclastogenesis in rats. PD was induced by means of ligature in nondiabetic and in streptozotocyn-induced DM1 rats. Morphological and morphometric analyses, stereology and osteoclast counting were performed. RANKL and OPG mRNA levels, protein content, and location were determined. PD caused alveolar bone resorption, increased the number of osteoclasts in the alveolar bone crest and also promoted changes in RANKL/OPG mRNA expression. DM1 alone showed alveolar bone destruction and an increased number of osteoclasts at the periapical and furcal regions. DM1 exacerbated these characteristics, with a greater impact on bone structure, resulting in a low OPG content and a higher RANKL/OPG ratio, which correlated with prominent osteoclastogenesis. This work demonstrates that the effects of PD and DM1 enhance bone destruction, confirms the importance of the RANKL signaling pathway in bone destruction in DM1 in animal models and suggests the existence of alternative mechanisms potentiating bone degradation in PD.

Keywords:
Alveolar bone, Type 1 diabetes mellitus, Ligature, Osteoprotegerin, Receptor activator of nuclear factor-kappaB ligand
1.
Bender, I.B., A.B. Bender (2003) Diabetes mellitus and the dental pulp. J Endod 29: 383–389.
2.
Bostanci, N., T. Ilgenli, G. Emingil, B. Afacan, B. Han, H. Toz, A. Berdeli, G. Atilla, I.J. McKay, F.J. Hughes, G.N. Belibasakis (2007) Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 42: 287–293.
3.
Botolin, S., L.R. McCabe (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99: 411–424.
4.
Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
5.
Claudino, M., D.S. Ceolin, S. Alberti, T.M. Cestari, C.T. Spadella, I.R. Rubira-Bullen, G.P. Garlet, G.F. de Assis (2007) Alloxan-induced diabetes triggers the development of periodontal disease in rats. PLoS One 2: e1320.
6.
Conget, I. (2002) Diagnosis, classification and cathogenesis of diabetes mellitus. Rev Esp Cardiol 55: 528–535.
7.
Crotti, T., M.D. Smith, R. Hirsch, S. Soukoulis, H. Weedon, M. Capone, M.J. Ahern, D. Haynes (2003) Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res 38: 380–387.
8.
de Amorim, F.P., S.S. Ornelas, S.F. Diniz, A.C. Batista, T.A. da Silva (2008) Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats. J Mol Histol 39: 401–408.
9.
de Aquino, S.G., M.R. Guimaraes, D.R. Stach-Machado, J.A. da Silva, L.C. Spolidorio, C. Rossa Jr (2009) Differential regulation of MMP-13 expression in two models of experimentally induced periodontal disease in rats. Arch Oral Biol 54: 609–617.
10.
Dew, G., G. Murphy, H. Stanton, R. Vallon, P. Angel, J.J. Reynolds, R.M. Hembry (2000) Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone. Cell Tissue Res 299: 385–394.
11.
Duarte, P.M., J.B. Neto, M.Z. Casati, E.A. Sallum, F.H. Nociti Jr (2007) Diabetes modulates gene expression in the gingival tissues of patients with chronic periodontitis. Oral Dis 13: 594–599.
12.
Ekuni, D., T. Yamamoto, R. Yamanaka, K. Tachibana, T. Watanabe (2003) Proteases augment the effects of lipopolysaccharide in rat gingiva. J Periodontal Res 38: 591–596.
13.
Gaffen, S.L., G. Hajishengallis (2008) A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87: 817–828.
14.
Garlet, G.P. (2010) Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 89: 1349–1363.
15.
Garlet, G.P., C.R. Cardoso, T.A. Silva, B.R. Ferreira, M.J. Avila-Campos, F.Q. Cunha, J.S. Silva (2006) Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 21: 12–20.
16.
Garlet, G.P., W. Martins Jr, B.A.L. Fonseca, B.R. Ferreira, J.S. Silva (2004) Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 31: 671–679.
17.
Gemmell, E., K. Yamazaki, G.J. Seymour (2007) The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000 43: 14–40.
18.
Graves, D.T., R. Liu, T.W. Oates (2007) Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol 2000 45: 128–137.
19.
Hikita, A., Y. Kadono, H. Chikuda, A. Fukuda, H. Wakeyama, H. Yasuda, K. Nakamura, H. Oda, T. Miyazaki, S. Tanaka (2005) Identification of an alternatively spliced variant of Ca2+-promoted Ras inactivator as a possible regulator of RANKL shedding. J Biol Chem 280: 41700–41706.
20.
Holzhausen, M., D.F. Garcia, M.T. Pepato, E. Marcantonio Jr (2004) The influence of short-term diabetes mellitus and insulin therapy on alveolar bone loss in rats. J Periodontal Res 39: 188–193.
21.
Huttunen, E., T. Romppanen, H.J. Helminen (1981) A histoquantitative study on the effects of castration on the rat ventral prostate lobe. J Anat 132: 357–370.
22.
Johnson, I.H. (1975) Effects of local irritation and dextran sulphate administration on the periodontium of the rat. J Periodontal Res 10: 332–345.
23.
Kawai, T., T. Matsuyama, Y. Hosokawa, S. Makihira, M. Seki, N.Y. Karimbux, R.B. Goncalves, P. Valverde, S. Dibart, Y.P. Li, L.A. Miranda, C.W. Ernst, Y. Izumi, M.A. Taubman (2006) B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 169: 987–998.
24.
Kitami, S., H. Tanaka, T. Kawato, N. Tanabe, T. Katono-Tani, F. Zhang, N. Suzuki, Y. Yonehara, M. Maeno (2010) IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie 92: 398–404.
25.
Kornman, K.S. (2001) Patients are not equally susceptible to periodontitis: does this change dental practice and the dental curriculum? J Dent Educ 65: 777–784.
26.
Liu, R., H.S. Bal, T. Desta, N. Krothapalli, M. Alyassi, Q. Luan, D.T. Graves (2006) Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 85: 510–514.
27.
Lorencini, M., J.A. Silva, C.A. Almeida, A. Bruni-Cardoso, H.F. Carvalho, D.R. Stach-Machado (2009a) A new paradigm in the periodontal disease progression: gingival connective tissue remodeling with simultaneous collagen degradation and fibers thickening. Tissue Cell 41: 43–50.
28.
Lorencini, M., J.A. Silva, C.L. de la Hoz, H.F. Carvalho, D.R. Stach-Machado (2009b) Changes in MMPs and inflammatory cells in experimental gingivitis. Histol Histopathol 24: 157–166.
29.
Mealey, B. (1999) Diabetes and periodontal diseases. J Periodontol 70: 935–949.
30.
Mealey, B.L., T.W. Oates (2006) Diabetes mellitus and periodontal diseases. J Periodontol 77: 1289–1303.
31.
Nagasawa, T., M. Kiji, R. Yashiro, D. Hormdee, H. Lu, M. Kunze, T. Suda, G. Koshy, H. Kobayashi, S. Oda, H. Nitta, I. Ishikawa (2007) Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease. Periodontol 2000 43: 65–84.
32.
Naquib, G., H. Al-Mashat, T. Desta, D.T. Graves (2004) Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 123: 87–92.
33.
Nishimura, F., Y. Iwamoto, Y. Soga (2007) The periodontal host response with diabetes. Periodontol 2000 43: 245–253.
34.
Ogawa, N., T. Yamaguchi, S. Yano, M. Yamauchi, M. Yamamoto, T. Sugimoto (2007) The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm Metab Res 39: 871–875.
35.
Oliver, R.C., T. Tervonen (1993) Periodontitis and tooth loss: comparing diabetics with the general population. J Am Dent Assoc 124: 71–76.
36.
Oliver, R.C., T. Tervonen (1994) Diabetes – a risk factor for periodontitis in adults? J Periodontol 65(5 suppl): 530–538.
37.
Oshiro, T., A. Shiotani, Y. Shibasaki, T. Sasaki (2002) Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec 266: 218–225.
38.
Persson, R.E., L.G. Hollender, M.I. MacEntee, C.C. Wyatt, H.A. Kiyak, G.R. Persson (2003) Assessment of periodontal conditions and systemic disease in older subjects. J Clin Periodontol 30: 207–213.
39.
Silva, J.A., M. Lorencini, L.A. Peroni, C.L. De La Hoz, H.F. Carvalho, D.R. Stach-Machado (2008a) The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease. J Periodontal Res 43: 48–54.
40.
Silva, J.A., M. Lorencini, J.R. Reis, H.F. Carvalho, V.H. Cagnon, D.R. Stach-Machado (2008b) The influence of type I diabetes mellitus in periodontal disease induced changes of the gingival epithelium and connective tissue. Tissue Cell 40: 283–292.
41.
Southerland, J.H., G.W. Taylor, K. Moss, J.D. Beck, S. Offenbacher (2006) Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontol 2000 40: 130–143.
42.
Takayanagi, H. (2010) New immune connections in osteoclast formation. Ann NY Acad Sci 1192: 117–123.
43.
Taubman, M.A., P. Valverde, X. Han, T. Kawai (2005) Immune response: the key to bone resorption in periodontal disease. J Periodontol 76(11 suppl): 2033–2041.
44.
Walsh, M.C., N. Kim, Y. Kadono, J. Rho, S.Y. Lee, J. Lorenzo, Y. Choi (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24: 33–63.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.